Teacher Retirement System of Texas boosted its stake in shares of Boston Scientific Corporation (NYSE:BSX) by 138.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 376,275 shares of the medical equipment provider’s stock after buying an additional 218,236 shares during the period. Teacher Retirement System of Texas’ holdings in Boston Scientific were worth $9,328,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of BSX. Cerebellum GP LLC acquired a new stake in Boston Scientific during the 4th quarter worth about $126,000. Valeo Financial Advisors LLC acquired a new stake in Boston Scientific during the 3rd quarter worth about $138,000. Steward Partners Investment Advisory LLC acquired a new stake in Boston Scientific during the 3rd quarter worth about $139,000. Ironwood Investment Counsel LLC acquired a new position in shares of Boston Scientific in the 3rd quarter valued at about $204,000. Finally, Perkins Capital Management Inc. acquired a new position in shares of Boston Scientific in the 3rd quarter valued at about $204,000. Hedge funds and other institutional investors own 89.84% of the company’s stock.

In related news, SVP David A. Pierce sold 8,763 shares of the stock in a transaction that occurred on Thursday, January 11th. The stock was sold at an average price of $27.74, for a total value of $243,085.62. Following the transaction, the senior vice president now owns 24,201 shares in the company, valued at $671,335.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP David A. Pierce sold 5,152 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $27.00, for a total value of $139,104.00. Following the completion of the transaction, the senior vice president now owns 38,116 shares in the company, valued at approximately $1,029,132. The disclosure for this sale can be found here. Insiders sold 177,032 shares of company stock worth $4,648,733 in the last 90 days. 0.74% of the stock is currently owned by corporate insiders.

A number of brokerages have recently weighed in on BSX. Barclays reiterated a “buy” rating and issued a $32.00 target price on shares of Boston Scientific in a report on Wednesday, January 10th. BMO Capital Markets reiterated a “buy” rating and issued a $31.00 target price on shares of Boston Scientific in a report on Wednesday, November 29th. Needham & Company LLC upgraded Boston Scientific from a “buy” rating to a “strong-buy” rating and upped their target price for the company from $25.04 to $32.00 in a report on Friday, December 8th. Oppenheimer reiterated a “hold” rating on shares of Boston Scientific in a report on Wednesday, November 29th. Finally, Canaccord Genuity dropped their target price on Boston Scientific from $36.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, November 29th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $31.00.

Boston Scientific Corporation (BSX) opened at $26.11 on Wednesday. Boston Scientific Corporation has a twelve month low of $23.29 and a twelve month high of $29.93. The company has a market capitalization of $35,950.27, a P/E ratio of 373.00, a P/E/G ratio of 1.90 and a beta of 0.81. The company has a quick ratio of 0.50, a current ratio of 0.72 and a debt-to-equity ratio of 0.58.

Boston Scientific (NYSE:BSX) last released its quarterly earnings data on Thursday, February 1st. The medical equipment provider reported $0.34 EPS for the quarter, hitting analysts’ consensus estimates of $0.34. Boston Scientific had a return on equity of 24.04% and a net margin of 1.15%. The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter in the prior year, the company posted $0.30 earnings per share. The firm’s revenue was up 9.9% on a year-over-year basis. analysts expect that Boston Scientific Corporation will post 1.37 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Boston Scientific Corporation (BSX) Holdings Increased by Teacher Retirement System of Texas” was first posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.dailypolitical.com/2018/02/14/boston-scientific-corporation-bsx-holdings-increased-by-teacher-retirement-system-of-texas.html.

Boston Scientific Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX).

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.